Synkromax Biotech Private Limited - Company Profile

It is a agriculture private limited company based in Thirumazhisai, Tamil Nadu, India, established in 2009.
2009 Thirumazhisai, Tamil Nadu, India Active
Last Updated:
Access Report
About Synkromax Biotech Private Limited

Synkromax Biotech Private Limited, a active private limited company, was established on 11 August 2009 in Thirumazhisai, Tamil Nadu, India. Engaging in agri support services within the manufacturing sector, it holds CIN: U74999TN2009PTC072537. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹10.78 Cr.

Formerly known as Shri Meera Biotech Private Limited. It upholds a compliant status. Employing 44 professional, Its leadership includes Usha Subramanian (Director), Subramanian Veluchamy (Managing Director). Past directors included Seshadri, Soma Guhathakurta, Arvind Kumar Chandak. It holds ₹46.88 Cr open charges and ₹19.73 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Module No.26 To 31, Ii Floor Sidco Multistoryed Complex, Sidco Indust, Rial Estat, Thirumazhisai, Tamil Nadu, 600124.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TN2009PTC072537

  • Registration Number

    072537

  • Incorporation Date

    11 August 2009

  • Authorized Capital

    ₹25.00 Cr

  • Paid-Up Capital

    ₹10.78 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 10.78 Cr
  • Company Age 16 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 46.88 Cr
  • Satisfied Charges ₹ 19.73 Cr
  • Revenue Growth **** 10.55%
  • Profit Growth **** -73.18%
  • Ebitda **** 3.54%
  • Net Worth 36.33%
  • Total Assets **** 16.08%
Company report

Synkromax Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Synkromax Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synkromax Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Usha Subramanian Director 20 Jul 2020 Current
Subramanian Veluchamy Managing Director 09 May 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 14 Jun 2020 Past
Pramod Abcsdd Director 13 Jul 2018 Past
Pramod Abcsdd Director 22 Oct 2018 Past
Pramod Abcsdd Director 15 Nov 2011 Past
Pramod Abcsdd Director 15 Nov 2011 Past
Pramod Abcsdd Director 26 Aug 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synkromax Biotech.

Synkromax Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.55% increase. The company also saw a substantial fall in profitability, with a 73.18% decrease in profit. The company's net worth Soared by an impressive increase of 36.33%.

Synkromax Biotech revenue growth over time
Synkromax Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 10.55%
*******
*******
*******
*******
Revenue from Operations
*******
 10.98%
*******
*******
*******
*******
Total Assets
*******
 16.08%
*******
*******
*******
*******
Profit or Loss
*******
 -73.18%
*******
*******
*******
*******
Net Worth
*******
 36.33%
*******
*******
*******
*******
EBITDA
*******
 3.54%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synkromax Biotech?

In 2023, Synkromax Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹468,800,000.00

Satisfied Charges

₹197,262,000.00

Charges Breakdown by Lending Institutions
  • Indian Overseas Bank : 46.85 Cr
  • Others : 0.03 Cr
Latest Charge Details
Date Lender Amount Status
15 Nov 2024 Indian Overseas Bank ₹46.85 Cr Open
23 Jan 2024 Others ₹0.30 M Open
12 Jan 2023 Bank Of India ₹1.18 Cr Satisfied
06 Aug 2021 Sidbi ₹1.44 Cr Satisfied
30 Mar 2021 Bank Of India ₹1.41 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Synkromax Biotech?

Synkromax Biotech has a workforce of 44 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synkromax Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synkromax Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synkromax Biotech
Recent Activity within the Organization
  • Charges

    The activity A charge with Indian Overseas Bank of Rs. 46.85 Cr registered on 15 Nov 2024 with Charge ID 101003461 was modified on 02 Dec 2024. was completed.

  • Charges

    Progress on A charge registered on 12 Jan 2023 via Charge ID 100679370 with Bank Of India was fully satisfied on 28 Nov 2024. was documented.

  • Charges

    Progress on A charge registered on 30 Mar 2021 via Charge ID 100447414 with Bank Of India was fully satisfied on 28 Nov 2024. was documented.

  • Charges

    The activity A charge registered on 27 Mar 2020 via Charge ID 100335711 with Bank Of India was fully satisfied on 28 Nov 2024. was completed.

  • Charges

    A charge registered on 09 Jan 2012 via Charge ID 10333712 with Bank Of India was fully satisfied on 28 Nov 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Indian Overseas Bank amounted to Rs. 46.85 Cr with Charge ID 101003461 was registered on 15 Nov 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synkromax Biotech Private Limited?

The CIN of Synkromax Biotech Private Limited is U74999TN2009PTC072537.

Where is Synkromax Biotech Private Limited headquartered?

Synkromax Biotech Private Limited is headquartered at Module No.26 To 31, Ii Floor Sidco Multistoryed Complex, Sidco Indust, Rial Estat, Thirumazhisai, Tamil Nadu, 600124.

When was Synkromax Biotech Private Limited incorporated?

Synkromax Biotech Private Limited was incorporated on 11 August 2009.

Who are the current directors of Synkromax Biotech Private Limited?

The current directors of Synkromax Biotech Private Limited are

What is the primary industry of Synkromax Biotech Private Limited?

The primary industry of Synkromax Biotech Private Limited is Manufacturing.

Is Synkromax Biotech Private Limited a listed company?

Synkromax Biotech Private Limited is unlisted.

What is the capital structure of Synkromax Biotech Private Limited?

The authorized capital of Synkromax Biotech Private Limited is ₹25.00 Cr, and the paid-up capital is ₹10.78 Cr.

What is the compliance status of Synkromax Biotech Private Limited?

The compliance status of Synkromax Biotech Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available